Is methylene blue FDA approved? What the label actually says

Last updated 2026-07-27

Is methylene blue FDA approved, and for what exactly?

Yes, but the approval is narrow. The FDA approved a methylene blue injection product called Provayblue (methylene blue injection, USP) in 2016 for treating acquired methemoglobinemia, a blood disorder where hemoglobin can't release oxygen properly ^[1]. That's the only FDA-approved indication for methylene blue as a drug product in the United States. The FDA's own label for Provayblue states the drug is indicated "for the treatment of adults and pediatric patients with acquired methemoglobinemia" ^[1]. That's it. There's no FDA-approved indication for cognitive enhancement, mitochondrial support, longevity, mood, or anti-aging use anywhere on that label. Methylene blue as a chemical has a long medical history, first synthesized in 1876 and used clinically since the late 1800s for malaria and later methemoglobinemia ^[2]. So the molecule is old and well characterized. The FDA-approved drug product for a specific use is much narrower than the compound's overall reputation. If you see a company claim methylene blue is "FDA approved" for focus, energy, or brain health, that claim is false on its face. The approval attaches to a specific product for a specific diagnosis, not to the ingredient for any use anyone wants.

What does 'FDA approved' actually mean for a drug like this?

FDA approval means a specific manufacturer's specific formulation, at a specific dose, cleared human trials showing it works and is reasonably safe for a named condition. It doesn't mean the underlying chemical is approved for anything you'd use it for. The FDA describes its drug approval process as requiring "substantial evidence of effectiveness" from adequate and well-controlled studies, plus a benefit-risk assessment specific to the proposed use ^[3]. Provayblue went through that process for methemoglobinemia only. Nobody has run that process for methylene blue as a nootropic or longevity agent, and the studies that exist for those uses are far smaller and often preclinical. This is why the distinction matters so much here. A pharmacy-compounded or supplement-market methylene blue product used for energy or focus is being used off-label, meaning outside its approved indication, even if the active ingredient is chemically identical to what's in Provayblue. Off-label use itself is legal for physicians to prescribe. What's not legal or safe is a manufacturer marketing an unapproved product as if the FDA approved it for that off-label purpose.

Is methylene blue used off-label for energy, focus, or anti-aging?

Yes, off-label use for cognitive and mitochondrial purposes happens, but the human evidence behind it is thin. Most of what circulates online rests on small trials, older single-dose studies, or animal and cell research, not large controlled human trials. The most cited human cognitive study is a 2016 crossover trial in healthy volunteers that found a single low dose of methylene blue (about 0.5 mg/kg) modestly improved short-term memory and reaction-related brain activity on fMRI, compared to placebo ^[4]. That's genuinely interesting pharmacology. It is not proof that daily low-dose methylene blue improves focus or energy over weeks or months, because the study wasn't designed to test that. The mitochondrial story comes mostly from cell and animal research showing methylene blue can act as an alternative electron carrier in the mitochondrial electron transport chain at low concentrations, which is a real biochemical mechanism studied since at least the 1960s-70s and revisited in more recent lab work ^[5]. Translating an electron-carrier effect in isolated mitochondria or rodent models into a reliable human energy or longevity benefit is a big, unproven jump. Longevity claims lean on rodent lifespan and stress-resistance studies, not human trials. Treat any anti-aging claim for methylene blue as preclinical until better human data exists, because right now, that's what it is. If you're evaluating dosing protocols people use for these off-label purposes, the practical questions (how much, how often, for how long) are covered separately: see Methylene Blue Bio dosage and Methylene Blue Bio cycle length.

What's the difference between pharmaceutical-grade and aquarium-grade methylene blue?

This is the single most important safety distinction in the whole topic. Pharmaceutical-grade methylene blue meets USP (United States Pharmacopeia) purity and manufacturing standards intended for injection or ingestion in humans. Aquarium-grade or industrial-grade methylene blue, sold for treating fish tank parasites or as a lab dye, is not held to that standard and can contain heavy metals, solvents, or other contaminants at levels never tested for human use. The FDA-approved Provayblue label specifies "methylene blue injection, USP" at a defined concentration (10 mg/mL) with defined excipients ^[1]. That specification exists precisely because purity, sterility, and concentration accuracy matter when something goes into a human bloodstream or bypasses the gut. Aquarium and craft-dye methylene blue is manufactured for fish tanks and textiles, with no requirement for pharmaceutical purity, sterility testing, or accurate labeling of trace contaminants. Buying that product to take internally isn't a gray area, it's a real risk, and there's no way for a consumer to verify purity by looking at a bottle. Any reputable source for human use should be explicit about USP-grade sourcing and ideally traceable to a licensed pharmacy. This is one of the two safety facts worth remembering above everything else in this article: grade matters, and non-pharmaceutical-grade methylene blue is not a shortcut, it's a different, riskier product.

Can methylene blue cause serotonin syndrome?

Yes, and this is the other critical safety fact. Methylene blue is a monoamine oxidase inhibitor (MAOI), and the FDA has issued a specific drug safety communication about serotonin syndrome when it's combined with serotonergic psychiatric medications. The FDA's communication states plainly that "methylene blue is a potent, reversible inhibitor of monoamine oxidase A (MAO-A)" and warns that combining it with serotonergic drugs, including SSRIs and SNRIs, can lead to serotonin syndrome, a serious and potentially fatal condition . The Provayblue label itself carries a warning against use with serotonergic drugs ^[1]. Serotonergic drugs that carry this risk include SSRIs like sertraline and fluoxetine, SNRIs like venlafaxine and duloxetine, MAOIs, tricyclic antidepressants, and some pain and migraine medications like tramadol and triptans. Serotonin syndrome symptoms include agitation, rapid heart rate, high blood pressure, dilated pupils, muscle rigidity, tremor, and in severe cases seizures and hyperthermia; it's a medical emergency. If you're on any antidepressant or serotonergic medication, this isn't a theoretical caution, it's a documented FDA warning with real case reports behind it, most in the context of methylene blue given during surgery to patients already on SSRIs . Anyone considering methylene blue for any purpose while on these medications should talk to a prescriber first, not experiment.

Who should not take methylene blue?

People with G6PD (glucose-6-phosphate dehydrogenase) deficiency should not take methylene blue except under close medical supervision, because it can trigger hemolytic anemia in this population. The Provayblue label explicitly states methylene blue is "contraindicated in patients with G6PD deficiency due to the risk of hemolytic anemia" ^[1]. G6PD deficiency is a genetic condition affecting red blood cells' ability to handle oxidative stress. It's common in people of African, Mediterranean, Middle Eastern, and Southeast Asian descent, and many people don't know they have it unless tested. Methylene blue relies on G6PD-dependent pathways to be reduced and cleared safely in the body; without that pathway working, it can instead cause the oxidative damage it's meant to treat. Other groups who need real caution: anyone on serotonergic medication (see above), pregnant or breastfeeding people (methylene blue crosses the placenta and there's documented fetal risk data prompting label warnings), people with kidney impairment (affects clearance), and anyone with a known sulfa or thiazine dye allergy. This isn't a supplement you self-dose around blindly. If G6PD status is unknown and there's a family or ethnic background history that raises risk, testing before use is a reasonable and cheap precaution.

What side effects and risks does methylene blue actually have?

At the doses used medically for methemoglobinemia, documented side effects include blue or green discoloration of urine and skin, nausea, headache, dizziness, chest pain, and at higher doses, the label warns methylene blue can paradoxically worsen methemoglobinemia or cause hemolytic anemia ^[1]. Blue-green urine is harmless and expected, just alarming if you don't know it's coming. More concerning effects like serotonin syndrome (with serotonergic drugs) and hemolytic anemia (with G6PD deficiency) are covered above and are the two risks worth taking most seriously. At higher doses, methylene blue itself can cause methemoglobinemia rather than treat it, a dose-dependent paradox noted in the prescribing information ^[1]. This is part of why dose accuracy matters so much, and why reconstitution and injection technique aren't places to improvise. See how to reconstitute Methylene Blue Bio, Methylene Blue Bio how to inject, and Methylene Blue Bio injection sites for the practical mechanics if a provider has recommended a specific protocol. Drug interaction risk isn't limited to serotonergic drugs either. Because it's an MAOI, methylene blue can interact with other medications metabolized through related pathways. A full medication review with a pharmacist or prescriber before starting is the responsible move, not an optional extra step.

Is methylene blue legal to buy without a prescription?

It depends entirely on the grade and the seller's claims. Pharmaceutical-grade methylene blue as an FDA-approved drug (Provayblue) requires a prescription. Lower-grade methylene blue sold as a lab reagent, aquarium treatment, or research chemical can be bought without a prescription, but it's not legal or safe to market or use those products for human ingestion or injection. The FDA doesn't regulate methylene blue sold explicitly as an aquarium additive or industrial dye as a drug, because it's not marketed as one. The problem arises when sellers market non-pharmaceutical-grade methylene blue with health claims (energy, focus, longevity) aimed at humans, which can trigger FDA action for unapproved drug claims, or when consumers buy non-human-grade product and use it anyway. A legitimate, provider-reviewed route means a licensed prescriber evaluates you, considers your medication list and G6PD status, and directs you to pharmaceutical-grade product through a licensed pharmacy. Methylene Blue Bio operates on a provider-reviewed model that connects people to that kind of oversight and to a fulfilling pharmacy partner for USP-grade product, rather than selling raw chemical directly. That structure exists specifically to keep the grade and the medical screening (serotonergic drug check, G6PD status) attached to the product, which matters more here than with most substances people buy online.

How is methylene blue different from a dietary supplement?

Methylene blue is not a dietary supplement, legally or chemically. It's a drug, whether it's the FDA-approved Provayblue formulation or a compounded, off-label version used for other purposes. A substance approved as a drug generally cannot also be lawfully marketed as a dietary supplement under FD&C Act rules on new dietary ingredients tied to approved drugs. This matters for quality control. Supplements are regulated under a much lighter framework than drugs; the FDA doesn't approve supplements before they reach the market, and manufacturers aren't required to prove efficacy. A product being sold as a supplement or research chemical, rather than as a prescribed drug, has skipped the oversight that would normally confirm its purity, dose accuracy, and sourcing. That's a big part of why the USP-grade distinction above matters so much: without drug-level oversight, there's no guaranteed floor on quality.

What should I ask before using methylene blue for energy or focus?

Ask whether the product is USP pharmaceutical-grade, ask whether a licensed provider has reviewed your medication list for serotonergic drugs, and ask about your G6PD status if you don't already know it. Those three questions cover the highest-stakes risks. Beyond safety screening, ask what dose is actually being proposed and why. Off-label protocols people discuss online vary widely, often citing the low doses (around 0.5 mg/kg or less) used in the 2016 cognitive study ^[4], far below doses used for methemoglobinemia treatment. More isn't better here; higher doses raise the paradoxical methemoglobinemia risk noted on the drug label ^[1]. Ask how long a cycle is meant to last and what monitoring, if any, happens during it. Nobody has published long-term human safety data for chronic low-dose methylene blue use in healthy people, so any claim of "safe for daily long-term use" for nootropic purposes is an extrapolation, not an established fact. Finally, ask who is actually reviewing your case: a real prescriber looking at your chart, or a checkout page. That difference is the whole ballgame for a drug with an MAOI interaction profile and a genetic contraindication.

Frequently asked questions

Is methylene blue FDA approved for energy or focus?

No. The only FDA-approved use for methylene blue is treating methemoglobinemia, via the drug Provayblue, approved in 2016. Energy, focus, cognitive, and anti-aging uses are off-label, meaning they're not FDA-reviewed for those purposes, regardless of what a seller's marketing implies.

What is Provayblue and how is it different from other methylene blue?

Provayblue is the FDA-approved brand name methylene blue injection, USP, cleared in 2016 specifically for acquired methemoglobinemia in adults and children. Chemically it's the same molecule found in compounded or lower-grade products, but its manufacturing, dosing, and purity are FDA-verified for that one indication.

Can I take methylene blue if I'm on an SSRI or SNRI?

This combination carries a real, FDA-flagged risk of serotonin syndrome because methylene blue is an MAOI. The FDA has issued a specific safety communication on this interaction. Don't combine them without a prescriber directly evaluating and approving it; this isn't a minor caution.

Does methylene blue interact with other medications besides antidepressants?

Yes, potentially. As an MAOI, methylene blue can interact with other drugs metabolized through monoamine pathways, more than SSRIs and SNRIs. A full medication review with a pharmacist or prescriber before use is the safe approach, since interaction risk isn't limited to psychiatric drugs alone.

Is aquarium-grade methylene blue safe to take?

No. Aquarium and industrial-grade methylene blue isn't manufactured or tested to human pharmaceutical (USP) standards and can carry contaminants like heavy metals or solvents. Only pharmaceutical-grade, USP methylene blue sourced through a licensed pharmacy is appropriate for human use.

What is G6PD deficiency and why does it matter for methylene blue?

G6PD deficiency is a genetic condition impairing red blood cells' antioxidant defenses. The FDA-approved label for methylene blue lists G6PD deficiency as a contraindication because it raises the risk of hemolytic anemia. Testing is worthwhile if you have unknown status and relevant ancestry or family history.

Is there human evidence methylene blue improves memory or cognition?

There's one notable 2016 crossover study in healthy adults showing a single low dose improved short-term memory and related brain activity on fMRI versus placebo. It's a real finding, but it's small, single-dose, and doesn't establish long-term benefit from repeated use.

Is the mitochondrial 'energy boost' claim about methylene blue proven in humans?

Not in the way marketing often implies. The mitochondrial electron-carrier mechanism is documented in cell and animal research going back decades. Human trials specifically testing energy or fatigue outcomes from methylene blue are lacking, so this claim rests on lab and rodent mechanism, not confirmed human results.

Can methylene blue be legally sold as a supplement?

No, not lawfully as a dietary supplement, because it's classified as a drug and has FDA-approved drug status (Provayblue). Products marketed as supplements with drug-like health claims for methylene blue have drawn FDA scrutiny in the past for exactly this reason.

What side effects should I expect from methylene blue?

Blue or green urine and skin discoloration are common and harmless. Nausea, headache, dizziness, and chest pain are documented on the FDA label. At high doses it can paradoxically worsen methemoglobinemia or, in G6PD-deficient people, cause hemolytic anemia.

How do I find a provider-reviewed source for methylene blue?

Look for a service where a licensed provider reviews your medication list and relevant health history (especially serotonergic drugs and G6PD status) before directing you to pharmaceutical-grade product through a licensed, fulfilling pharmacy, rather than a site that simply ships raw chemical to anyone who orders.

Is methylene blue safe during pregnancy?

It's a real concern area. Methylene blue crosses the placenta and there's documented data prompting specific label warnings around fetal risk. Pregnant or breastfeeding people should not use methylene blue for off-label energy or cognitive purposes without direct guidance from an OB or prescriber.

Sources

1. FDA, Provayblue (methylene blue injection, USP) prescribing information, NDA 209471: FDA-approved indication for methemoglobinemia, G6PD contraindication, dosing and warnings
2. National Library of Medicine, StatPearls: Methylene Blue: History and pharmacology of methylene blue as a medical compound
3. FDA, The Drug Development Process, Step 3: Clinical Research: Description of FDA drug approval process requiring substantial evidence of effectiveness
4. Rodriguez et al., Radiology, 2016, single-dose methylene blue and memory/fMRI in healthy volunteers, PMID 27285392: Single low-dose methylene blue improved short-term memory and brain activity in a human crossover trial
5. National Library of Medicine, PMC review on methylene blue mitochondrial mechanism, PMC3423873: Methylene blue acting as an alternative electron carrier in mitochondrial electron transport, based on lab/animal research